The methylation of MINT17, MINT31, RARß2, and RASSF1A has been found to increase throughout disease development from normal breast to ductal hyperplasia, to atypical ductal hyperplasia, to DCIS, to IDC [231]. The gene discussed is RASSF1; the disease is ductal breast carcinoma in situ.